$Altimmune_老虎社区_美港股上老虎

白日梦想甲乙丙
2025-06-30

$Altimmune, Inc.(ALT)$ 这波操作真秀！24周疗程设计比48周节省半年时间，上市进度直接弯道超车。$诺和诺德(NVO)$ 和$礼来(LLY)$ 的GLP-1药物虽坐拥减重+代谢健康双重疗效，但咱们的数据更硬核，研发周期还砍半。要是能抢先上市，这印钞机可就转起来了——减肥群众吃着减重药还能白嫖肝脏修复功能，$安进(AMGN)$ 和$吉利德科学(GILD)$ 的MASH市场份额怕是要被咱们包圆。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

鹏程夜色
·2025-08-04
我觉得太乐观了，这只是局部进程而已，最后的实验数据没出来之前，只能说还行。。
回复
点赞
举报

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":451795302432928,"tweetId":"451795302432928","gmtCreate":1751295423000,"gmtModify":1751314570045,"author":{"id":10000000000010592,"idStr":"10000000000010592","authorId":10000000000010592,"authorIdStr":"10000000000010592","name":"白日梦想甲乙丙","avatar":"https://static.tigerbbs.com/a695eb9a7829510a2f199f476464205a","vip":8,"userType":8,"introduction":".","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":35,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/9abc1c8d38fbdb543364b27975822a2f","width":"1464","height":"808"}],"coverImages":[{"img":"https://static.tigerbbs.com/9abc1c8d38fbdb543364b27975822a2f","width":"1464","height":"808"}],"html":"<html><head></head><body><a href=\"https://laohu8.com/S/ALT\">$Altimmune, Inc.(ALT)$&nbsp;</a>这波操作真秀！24周疗程设计比48周节省半年时间，上市进度直接弯道超车。<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$&nbsp;</a>和<a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$&nbsp;</a>的GLP-1药物虽坐拥减重+代谢健康双重疗效，但咱们的数据更硬核，研发周期还砍半。要是能抢先上市，这印钞机可就转起来了——减肥群众吃着减重药还能白嫖肝脏修复功能，<a href=\"https://laohu8.com/S/AMGN\">$安进(AMGN)$&nbsp;</a>和<a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$&nbsp;</a>的MASH市场份额怕是要被咱们包圆。\n<img src=\"https://static.tigerbbs.com/9abc1c8d38fbdb543364b27975822a2f\" tg-width=\"1464\" tg-height=\"808\"></body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/ALT\">$Altimmune, Inc.(ALT)$&nbsp;</a>这波操作真秀！24周疗程设计比48周节省半年时间，上市进度直接弯道超车。<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$&nbsp;</a>和<a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$&nbsp;</a>的GLP-1药物虽坐拥减重+代谢健康双重疗效，但咱们的数据更硬核，研发周期还砍半。要是能抢先上市，这印钞机可就转起来了——减肥群众吃着减重药还能白嫖肝脏修复功能，<a href=\"https://laohu8.com/S/AMGN\">$安进(AMGN)$&nbsp;</a>和<a href=\"https://laohu8.com/S/GILD\">$吉利德科学(GILD)$&nbsp;</a>的MASH市场份额怕是要被咱们包圆。\n<img src=\"https://static.tigerbbs.com/9abc1c8d38fbdb543364b27975822a2f\" tg-width=\"1464\" tg-height=\"808\"></body></html>","text":"$Altimmune, Inc.(ALT)$ 这波操作真秀！24周疗程设计比48周节省半年时间，上市进度直接弯道超车。$诺和诺德(NVO)$ 和$礼来(LLY)$ 的GLP-1药物虽坐拥减重+代谢健康双重疗效，但咱们的数据更硬核，研发周期还砍半。要是能抢先上市，这印钞机可就转起来了——减肥群众吃着减重药还能白嫖肝脏修复功能，$安进(AMGN)$ 和$吉利德科学(GILD)$ 的MASH市场份额怕是要被咱们包圆。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/451795302432928","repostId":0,"isVote":1,"tweetType":1,"viewCount":3192,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ALT","GILD","LLY","AMGN","NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":326,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":463961797054960,"commentId":"463961797054960","gmtCreate":1754277306793,"gmtModify":1754277504028,"authorId":4184319806668240,"author":{"id":4184319806668240,"idStr":"4184319806668240","authorId":4184319806668240,"name":"鹏程夜色","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":451795302432928,"objectIdStr":"451795302432928","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"我觉得太乐观了，这只是局部进程而已，最后的实验数据没出来之前，只能说还行。。","text":"我觉得太乐观了，这只是局部进程而已，最后的实验数据没出来之前，只能说还行。。","html":"我觉得太乐观了，这只是局部进程而已，最后的实验数据没出来之前，只能说还行。。","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}

评论（1）

热议股票